 Topical Bactroban mupirocin efficacy burn wounds methicillin-resistant staphylococci Bacterial antimicrobial susceptibility predictors minimal inhibitory concentration MIC assay Agar Well Diffusion NAWD essential information relevant therapeutic approach burn-wound sepsis susceptibilities gram-positive burn-wound isolates topical Bactroban mupirocin Beecham Bristol topical antimicrobials mafenide acetate sulfadiazine bacitracin/neomycin/polymyxin BNP Topical susceptibility data modification NAWD Bactroban antimicrobial activity mafenide acetate vs silver sulfadiazine BNP isolates susceptible Bactroban methicillin-resistant staphylococci MRSA Bactroban vitro activity gram-negative isolates Mafenide acetate activity isolates significant difference Bactroban general significant difference activities Bactroban sulfadiazine gram-negative isolates activities mafenide acetate silver sulfadiazine isolates Pseudomonas aeruginosa Bactroban Bactroban treatment documented staphylococcal burn-wound infections basis vitro data patients MRSA burn-wound infections susceptible Bactroban Quantitative wound biopsies efficacy therapeutic approach outcome infections NAWD patients